Management of Nightmare Disorder in Adults

Erin D. Callen, PharmD, BCPS; Tiffany L. Kessler, PharmD, BCPS; Krista G. Brooks, PharmD; Tom W. Davis, MD


US Pharmacist. 2018;43(11):21-26. 

In This Article

Therapy Selection

In 2018, the American Academy of Sleep Medicine (AASM) published a position paper on the treatment of nightmare disorder that replaced their best-practice guide from 2010.[3] Treatment options are designated recommended or not recommended if they are clearly useful or harmful based on clinical evidence. The may be used position is designated when evidence is less clear. The AASM further differentiates treatments for PTSD-associated nightmares and nightmares without a clear etiology (which is termed nightmare disorder).3 Although selection of therapy depends on the clinician and the patient's access to resources, pharmacists should be aware of the various treatment options discussed in the position paper.